More and more implants are placed on top of the chest muscle (prepectoral) instead of under it. Patients have less pain, and the breast does not move when the muscle tightens. But the muscle was also padding. Without it, small folds in the implant can show through the skin. This is called rippling. This article explains how common it is and how it is treated.
In short
- About 1 in 5 patients show some rippling after a prepectoral reconstruction.
- It happens because the skin over the implant is thin.
- Firmer implants ripple less.
- Fat grafting, moving a little of the patient’s own fat over the implant, is the usual treatment.
- Rippling is a touch-up problem. It does not mean the reconstruction has failed.
What rippling is
How common it is
The clearest numbers come from 405 nipple-sparing mastectomies in one hospital, about half with the implant on top of the muscle and half under it. Rippling was seen in 15.3% on top of the muscle and 6.1% under it. But fat grafting was needed about equally often in both groups, 12.3% and 11.6%.1
Longer follow-up gives similar figures. In 90 patients followed for up to 4.3 years, rippling was seen in 19.4% and fat grafting was done in 23.7%.2 In 62 patients with large breasts, rippling was seen in 19% and 29% had fat grafting.3
So rippling is common enough to discuss with every patient before surgery. In these studies the reconstructions were kept, and the rippling was treated.
What makes it more likely
In the implant study, firmer implants were also linked to far fewer return operations for fat grafting.4 Some surgeons use firm, round implants routinely on top of the muscle for this reason.5
How fat grafting helps
Fat grafting treats the cause. Fat is taken from the tummy or thighs, cleaned, and placed in the thin layer over the implant. Surgeons at Johns Hopkins describe it as the typical way to correct rippling in these patients.6 For how much to place and when, see planning fat grafting sessions.
The same pattern is seen with a bovine pericardium matrix. In 65 reconstructions with an ExaShape® pocket, 7 patients had fat grafting after six months for rippling or wrinkling. No significant capsular contracture (hardening of scar tissue around the implant) was seen at a mean follow-up of 21.3 months.7 A matrix supports the implant. It does not replace the padding that fat gives.
The two studies of grafting on the day are small, each from one hospital.8 9
How the fat is prepared matters
Only part of the grafted fat survives. How the fat is collected and cleaned affects how much stays. See what determines fat graft retention. EXAFAT® is a closed system designed for preparing fat for breast grafting. Surgeons should follow its Instructions for Use. On safety after breast cancer, see this review.
What it means in practice
Tell every patient that rippling can happen, that it can usually be treated, and that a fat grafting session may be part of the plan. Choose the implant with rippling in mind. Look closely at the skin in the upper and inner breast. And when rippling appears, treat it as an expected touch-up.
References
- King CA, Bartholomew AJ, Sosin M, et al. A critical appraisal of late complications of prepectoral versus subpectoral breast reconstruction following nipple-sparing mastectomy. Ann Surg Oncol. 2021;28(13):9150-9158. doi:10.1245/s10434-021-10085-z
- Nahabedian MY. What are the long-term aesthetic issues in prepectoral breast reconstruction? Aesthet Surg J. 2020;40(Suppl 2):S29-S37. doi:10.1093/asj/sjaa164
- Salgarello M, Fabbri M, Visconti G, et al. Immediate breast reconstruction with prepectoral polyurethane-covered implant after conservative mastectomy in large and ptotic breasts. Aesthetic Plast Surg. 2025;49(23):6555-6564. doi:10.1007/s00266-025-05070-w
- Parikh N, Gadiraju GK, Prospero M, et al. The impact of breast implant cohesivity on rippling and revision procedures in 2-stage prepectoral breast reconstruction. Aesthet Surg J Open Forum. 2024;6:ojae028. doi:10.1093/asjof/ojae028
- Sbitany H, Lee KR. Optimizing outcomes in 2-stage prepectoral breast reconstruction utilizing round form-stable implants. Plast Reconstr Surg. 2019;144(1S):43S-50S. doi:10.1097/PRS.0000000000005949
- Darrach H, Kraenzlin F, Khavanin N, Chopra K, Sacks JM. The role of fat grafting in prepectoral breast reconstruction. Gland Surg. 2019;8(1):61-66. doi:10.21037/gs.2018.10.09
- De Vita R, Mangialardi ML, Pozzi M, et al. A pericardium bovine matrix pocket in DTI prepectoral breast reconstruction. Clin Breast Cancer. 2024;24(7):e613-e621. doi:10.1016/j.clbc.2024.06.004
- Gronovich Y, Winder G, Maisel-Lotan A, et al. Hybrid prepectoral direct-to-implant and autologous fat graft simultaneously in immediate breast reconstruction: a single surgeon’s experience with 25 breasts in 15 consecutive cases. Plast Reconstr Surg. 2022;149(3):386e-391e. doi:10.1097/PRS.0000000000008879
- Longo B, Giacalone M, D’Orsi G, et al. Immediate hybrid breast reconstruction: dual-plane approach using prepectoral implants and retropectoral fat grafting. Plast Reconstr Surg. 2025;156(2):209-222. doi:10.1097/PRS.0000000000011984
Important information This article is general education, not medical advice. Tap to read the full medical, regulatory & legal notice.
This article is provided by Advanced Biomedical Concept for general informational and educational purposes only. It does not constitute medical, surgical, diagnostic, or other professional healthcare advice, and it is not a substitute for consultation with a suitably qualified healthcare professional. Reading it creates no doctor–patient or other professional relationship. Nothing here should be used to diagnose, treat, cure, or prevent any disease or condition, or to make decisions about medical care. Always seek the advice of a physician or other qualified provider with any questions about a medical condition or treatment, and never disregard or delay professional advice because of something you have read here.
Any reference to Advanced Biomedical Concept products (including ExaShape and ExaFat) is provided for general information only. These are medical devices intended to be used by appropriately trained healthcare professionals strictly in accordance with their applicable, current Instructions for Use (IFU). Regulatory status (including CE marking and classification under the EU Medical Device Regulation), market availability, and approved indications differ between countries and may change over time; a device referred to here may not be available or approved in your country. This content is not intended as, and must not be relied upon as, a statement or claim of safety, clinical performance, or efficacy beyond what is set out in the applicable IFU and current regulatory approvals. Product-specific information is directed at healthcare professionals and is not intended to promote, advertise, or offer any medical device to the general public where such promotion is restricted or prohibited by law.
Statements reflect information believed to be accurate at the date of publication and may be updated or corrected without notice. Any statements regarding the future are expectations or general views, not guarantees. Clinical outcomes depend on many individual factors, results vary from person to person, and no particular result is promised or implied. Where third-party studies, sources, or external links are referenced, they are provided for convenience and information only and do not imply endorsement, and Advanced Biomedical Concept is not responsible for their content.
To the fullest extent permitted by applicable law, Advanced Biomedical Concept and its officers, employees, contributors, and representatives (each acting in that capacity and on behalf of Advanced Biomedical Concept) accept no liability for any loss, injury, or damage of any kind arising directly or indirectly from use of, or reliance on, this content. Nothing in this notice excludes or limits any liability that cannot lawfully be excluded or limited.
Questions about this material can be directed to us via our contact page.
Last reviewed: November 16, 2026.